Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy
- 1 December 2015
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 48 (18) , 1324-1329
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (NSC 101-2314-B-016-017, NSC 102-2314-B-016-012)
- Tri-Service General Hospital (TSGH-C102-108)
This publication has 23 references indexed in Scilit:
- suPAR as a prognostic biomarker in sepsisBMC Medicine, 2012
- Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsisJournal of Infection, 2011
- The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndromeClinical Biochemistry, 2011
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosisNature Medicine, 2011
- Modification of kidney barrier function by the urokinase receptorNature Medicine, 2007
- Urokinase-Receptor (u-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/dormancy, Clinical Outcome and Minimal Residual DiseaseCell Cycle, 2006
- Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: Modulation by angiotensin-converting–enzyme inhibitorJournal of Laboratory and Clinical Medicine, 2004
- Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivoFEBS Letters, 2000
- Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPARStem Cells, 1997
- Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidneyKidney International, 1996